. 2021 Feb 11;3(3):173–184. doi: 10.1002/acr2.11232

Table 2.

Covariates included in PS modeling

Covariates Included for Each Outcome	Covariates With STDs >\|0.10\|
Age Gender History of AE of interest (yes vs no) ^a Number of prior DMARDs Patient pain ^b Patient fatigue ^b HAQ ^b EQ‐5D ^b	Single marital status (yes versus no) Duration of RA Work status: Full time (yes versus no) Disabled (yes versus no) History of SIEs (yes vs no) Current concomitant medication

Covariates Included for Each Outcome

Covariates With STDs >|0.10|

Age

Gender

History of AE of interest (yes vs no) ^a

Number of prior DMARDs

Patient pain ^b

Patient fatigue ^b

HAQ ^b

EQ‐5D ^b

Single marital status (yes versus no)

Duration of RA

Work status:

Full time (yes versus no)

Disabled (yes versus no)

History of SIEs (yes vs no)

Current concomitant medication

AE, adverse event; DMARD, disease‐modifying antirheumatic drug; EQ‐5D, EuroQol Five‐Dimensions Health Questionnaire; HAQ, Health Assessment Questionnaire; PS, propensity score; RA, rheumatoid arthritis; SIE, serious infection event; STD, standardized difference.

^{^a}

Excluding death, and cardiovascular disease–related deaths for major adverse cardiovascular events.

^{^b}

Included in PS modeling for malignancy/death only.